Related Experiment Video

Updated: May 19, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells

F Esra Onen-Bayram1, Irem Durmaz, Daniel Scherman

  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Yeditepe University, Kadıkoy, 34755 Istanbul, Turkey.

Bioorganic & Medicinal Chemistry
|August 8, 2012
PubMed

Insights

Researchers identified a novel thiazolidine compound (ALC67) that effectively induces apoptosis in cancer cells. This compound shows potent cytotoxic activity, particularly against liver cancer, by activating a key cell death pathway.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Thiazolidine derivatives are recognized for their potential anticancer properties.
  • Chemogenomics is a valuable strategy for identifying novel therapeutic agents.
  • Targeting apoptosis is a critical approach in cancer treatment.

Purpose of the Study:

  • To identify novel thiazolidine compounds with cytotoxic and apoptosis-inducing properties.
  • To evaluate the anticancer activity of designed thiazolidine derivatives against various cancer cell lines.
  • To elucidate the mechanism of action of the most potent compound.

Main Methods:

  • Forward chemogenomics screening.
  • Synthesis and chemical structure design of thiazolidine compounds.
  • In vitro cytotoxicity assays on liver, breast, colon, and endometrial cancer cell lines.
  • Cell cycle analysis and apoptosis assays (caspase-9 activation).

Main Results:

  • Compound 3 (ALC67) exhibited significant cytotoxic activity (IC50 ~5 μM) against tested cancer cell lines.
  • ALC67 induced SubG1/G1 phase arrest and apoptosis in liver cancer cells.
  • The compound's cytotoxicity is mediated by the activation of the caspase-9 apoptotic pathway, independent of death receptors.

Conclusions:

  • The novel thiazolidine compound ALC67 is a potent apoptosis-inducing agent with significant cytotoxic effects on cancer cells.
  • ALC67 represents a promising lead compound for developing new anticancer therapies.
  • The caspase-9 pathway activation mechanism offers insights into its therapeutic potential.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.